Centene (NYSE:CNC – Get Free Report) had its target price boosted by investment analysts at Royal Bank Of Canada from $71.00 to $73.00 in a report issued on Friday, Benzinga reports. The brokerage currently has a “sector perform” rating on the stock. Royal Bank Of Canada‘s price target would suggest a potential upside of 11.65% from the stock’s previous close.
A number of other research firms have also recently commented on CNC. Robert W. Baird upped their target price on Centene from $66.00 to $71.00 and gave the company a “neutral” rating in a research note on Wednesday, October 28th. Bank of America reissued a “buy” rating and set a $82.00 price target (up from $80.00) on shares of Centene in a research note on Wednesday, October 28th. Weiss Ratings upgraded Centene from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, October 28th. Sanford C. Bernstein restated an “outperform” rating and set a $90.00 price objective on shares of Centene in a report on Tuesday. Finally, Zacks Research downgraded Centene from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Nine research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Centene currently has a consensus rating of “Hold” and an average target price of $75.20.
View Our Latest Analysis on Centene
Centene Trading Down 0.3%
Shares of CNC opened at $65.38 on Friday. The company’s fifty day simple moving average is $67.46 and its 200-day simple moving average is $57.06. The company has a market cap of $32.37 billion, a P/E ratio of 22.35, a P/E/G ratio of 0.39 and a beta of 1.07. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.69. Centene has a twelve month low of $31.63 and a twelve month high of $78.08.
Centene (NYSE:CNC – Get Free Report) last released its quarterly earnings results on Tuesday, October 27th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.48. The firm had revenue of $50.65 billion during the quarter, compared to analysts’ expectations of $47.12 billion. Centene had a net margin of 0.72% and a return on equity of 12.15%. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.50 EPS. As a group, analysts expect that Centene will post 5.27 EPS for the current year.
Insider Buying and Selling
In other news, General Counsel Christopher Koster sold 56,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the transaction, the general counsel directly owned 248,854 shares of the company’s stock, valued at approximately $16,648,332.60. This trade represents a 18.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.37% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Frank Rimerman Advisors LLC increased its holdings in Centene by 3.7% during the 3rd quarter. Frank Rimerman Advisors LLC now owns 4,521 shares of the company’s stock worth $281,000 after purchasing an additional 163 shares during the period. Journey Retirement Planning & Investment Management LLC lifted its holdings in shares of Centene by 3.9% in the 3rd quarter. Journey Retirement Planning & Investment Management LLC now owns 4,652 shares of the company’s stock worth $289,000 after buying an additional 175 shares during the period. Meeder Asset Management Inc. lifted its holdings in shares of Centene by 0.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 25,069 shares of the company’s stock worth $1,557,000 after buying an additional 208 shares during the period. Grove Bank & Trust grew its position in shares of Centene by 2.0% during the 3rd quarter. Grove Bank & Trust now owns 11,294 shares of the company’s stock worth $702,000 after buying an additional 220 shares in the last quarter. Finally, GoalVest Advisory LLC grew its position in shares of Centene by 25.9% during the 3rd quarter. GoalVest Advisory LLC now owns 1,122 shares of the company’s stock worth $70,000 after buying an additional 231 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.
Centene Company Profile
Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.
See Also
- Five stocks we like better than Centene
- Palo Alto Networks’ Q1 Beat Gives Its Stock Rally Another Reason to Run
- Airfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter Test
- Hard Drives Were Left for Dead, But Seagate and Western Digital Are Soaring
- Tesla and SpaceX May Form a $3.4 Trillion Giant, But Who Really Benefits?
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
